A Detailed Analysis of the Bioimpedance Spectroscopy Market Based on Growing Expanse of Wearable Health Technology, and Greater Emphasis on Research
Industry: Healthcare
Published Date: January-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 185
Report ID: PMRREP33713
1. Executive Summary
1.1. Global Bioimpedance Spectroscopy Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Product Lifecycle Analysis
2.4. Bioimpedance Spectroscopy Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Bioimpedance Spectroscopy Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Bioimpedance Spectroscopy Market Outlook: Product
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
3.3.3.1. Single Frequency Bioimpedance Spectroscopy
3.3.3.2. Multiple Frequency Bioimpedance spectroscopy
3.4. Market Attractiveness Analysis: Product
3.5. Global Bioimpedance Spectroscopy Market Outlook: Modality
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Modality, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Modality, 2023 - 2030
3.5.3.1. Hand-held BIA
3.5.3.2. Hand-to-Foot BIA
3.5.3.3. Leg-to-Leg BIA
3.6. Market Attractiveness Analysis: Modality
3.7. Global Bioimpedance Spectroscopy Market Outlook: End User
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
3.7.3.1. Hospitals
3.7.3.2. Specialty Clinics
3.7.3.3. Ambulatory Surgical Centers
3.7.3.4. Rehabilitation Center
3.8. Market Attractiveness Analysis: End User
4. Global Bioimpedance Spectroscopy Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia & Pacific
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Bioimpedance Spectroscopy Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Product
5.3.3. By Modality
5.3.4. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
5.5.1. Single Frequency Bioimpedance Spectroscopy
5.5.2. Multiple Frequency Bioimpedance spectroscopy
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Modality, 2023 - 2030
5.6.1. Hand-held BIA
5.6.2. Hand-to-Foot BIA
5.6.3. Leg-to-Leg BIA
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
5.7.1. Hospitals
5.7.2. Specialty Clinics
5.7.3. Ambulatory Surgical Centers
5.7.4. Rehabilitation Center
5.8. Market Attractiveness Analysis
6. Europe Bioimpedance Spectroscopy Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Product
6.3.3. By Modality
6.3.4. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Turkey
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
6.5.1. Single Frequency Bioimpedance Spectroscopy
6.5.2. Multiple Frequency Bioimpedance spectroscopy
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Modality, 2023 - 2030
6.6.1. Hand-held BIA
6.6.2. Hand-to-Foot BIA
6.6.3. Leg-to-Leg BIA
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
6.7.1. Hospitals
6.7.2. Specialty Clinics
6.7.3. Ambulatory Surgical Centers
6.7.4. Rehabilitation Center
6.8. Market Attractiveness Analysis
7. East Asia Bioimpedance Spectroscopy Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Product
7.3.3. By Modality
7.3.4. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
7.5.1. Single Frequency Bioimpedance Spectroscopy
7.5.2. Multiple Frequency Bioimpedance spectroscopy
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Modality, 2023 - 2030
7.6.1. Hand-held BIA
7.6.2. Hand-to-Foot BIA
7.6.3. Leg-to-Leg BIA
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
7.7.1. Hospitals
7.7.2. Specialty Clinics
7.7.3. Ambulatory Surgical Centers
7.7.4. Rehabilitation Center
7.8. Market Attractiveness Analysis
8. South Asia & Oceania Bioimpedance Spectroscopy Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Product
8.3.3. By Modality
8.3.4. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
8.5.1. Single Frequency Bioimpedance Spectroscopy
8.5.2. Multiple Frequency Bioimpedance spectroscopy
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Modality, 2023 - 2030
8.6.1. Hand-held BIA
8.6.2. Hand-to-Foot BIA
8.6.3. Leg-to-Leg BIA
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
8.7.1. Hospitals
8.7.2. Specialty Clinics
8.7.3. Ambulatory Surgical Centers
8.7.4. Rehabilitation Center
8.8. Market Attractiveness Analysis
9. Latin America Bioimpedance Spectroscopy Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Product
9.3.3. By Modality
9.3.4. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
9.5.1. Single Frequency Bioimpedance Spectroscopy
9.5.2. Multiple Frequency Bioimpedance spectroscopy
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Modality, 2023 - 2030
9.6.1. Hand-held BIA
9.6.2. Hand-to-Foot BIA
9.6.3. Leg-to-Leg BIA
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
9.7.1. Hospitals
9.7.2. Specialty Clinics
9.7.3. Ambulatory Surgical Centers
9.7.4. Rehabilitation Center
9.8. Market Attractiveness Analysis
10. Middle East & Africa Bioimpedance Spectroscopy Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Product
10.3.3. By Modality
10.3.4. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
10.5.1. Single Frequency Bioimpedance Spectroscopy
10.5.2. Multiple Frequency Bioimpedance spectroscopy
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Modality, 2023 - 2030
10.6.1. Hand-held BIA
10.6.2. Hand-to-Foot BIA
10.6.3. Leg-to-Leg BIA
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
10.7.1. Hospitals
10.7.2. Specialty Clinics
10.7.3. Ambulatory Surgical Centers
10.7.4. Rehabilitation Center
10.8. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Multiple Frequency Bioimpedance spectroscopy
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Tanita Corporation
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Akern
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. Biodynamics Corporation
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Bioparhom
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Biotekna
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. Bodystat Ltd
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Charder Electronic Co. Ltd
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Evolt 360
11.3.8.1. Overview
11.3.8.2. Segments and Product
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. Fook Tin Group Holding Ltd
11.3.9.1. Overview
11.3.9.2. Segments and Product
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. InBody Co. Ltd
11.3.10.1. Overview
11.3.10.2. Segments and Product
11.3.10.3. Key Financials
11.3.10.4. Market Developments
11.3.10.5. Market Strategy
11.3.11. Lumsail Industrial Inc.
11.3.11.1. Overview
11.3.11.2. Segments and Product
11.3.11.3. Key Financials
11.3.11.4. Market Developments
11.3.11.5. Market Strategy
11.3.12. Maltron International
11.3.12.1. Overview
11.3.12.2. Segments and Product
11.3.12.3. Key Financials
11.3.12.4. Market Developments
11.3.12.5. Market Strategy
11.3.13. Omron Corporation
11.3.13.1. Overview
11.3.13.2. Segments and Product
11.3.13.3. Key Financials
11.3.13.4. Market Developments
11.3.13.5. Market Strategy
11.3.14. RJL Systems
11.3.14.1. Overview
11.3.14.2. Segments and Product
11.3.14.3. Key Financials
11.3.14.4. Market Developments
11.3.14.5. Market Strategy
11.3.15. Seca GmbH & Co. KG
11.3.15.1. Overview
11.3.15.2. Segments and Product
11.3.15.3. Key Financials
11.3.15.4. Market Developments
11.3.15.5. Market Strategy
11.3.16. SELVAS Healthcare Inc.
11.3.16.1. Overview
11.3.16.2. Segments and Product
11.3.16.3. Key Financials
11.3.16.4. Market Developments
11.3.16.5. Market Strategy
11.3.17. Sino-Hero
11.3.17.1. Overview
11.3.17.2. Segments and Product
11.3.17.3. Key Financials
11.3.17.4. Market Developments
11.3.17.5. Market Strategy
11.3.18. Withings
11.3.18.1. Overview
11.3.18.2. Segments and Product
11.3.18.3. Key Financials
11.3.18.4. Market Developments
11.3.18.5. Market Strategy
11.3.19. ImpediMed Ltd.
11.3.19.1. Overview
11.3.19.2. Segments and Product
11.3.19.3. Key Financials
11.3.19.4. Market Developments
11.3.19.5. Market Strategy
11.3.20. Samsung
11.3.20.1. Overview
11.3.20.2. Segments and Product
11.3.20.3. Key Financials
11.3.20.4. Market Developments
11.3.20.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations